Business profile & competitive position
Lam Research Corporation operates in the Technology sector, classified under the Semiconductors industry, and sits at the capital-equipment layer of the chip supply chain. The company designs and sells wafer fabrication equipment and related services that logic, memory, and foundry customers use to build advanced semiconductors. The Semiconductor industry is one of the most concentrated segments of Technology, with only a handful of vendors able to supply the etch, deposition, and clean systems needed at leading-edge process nodes.
The financial footprint points toward meaningful competitive strength. The reported net margin is 31.3% and ROE is 67.0%, both well above the average for large-cap industrials. A net margin above 30% generally signals pricing power and a high degree of process know-how, while an ROE near 67% indicates that equity capital is being converted into earnings at an extremely high rate. Those figures are consistent with a supplier that holds entrenched positions in a consolidated equipment market. At the same time, the beta of 1.80 tells a different side of the story: the stock is structurally more volatile than the broad market, which is typical for a cyclical, capex-heavy business whose customers time large fab spending decisions to industry upturns and downturns.
Financial posture
LRCX currently commands a market capitalization of $389.4 billion, placing it among the largest names in the semiconductor equipment space. That scale is paired with a trailing P/E ratio of 53.8, a level that prices in strong forward growth expectations rather than a mature, slow-growth multiple. The P/E sits far above what a typical industrial company would carry, and it only makes sense if investors expect persistently high demand for advanced chip manufacturing capacity.
The valuation looks less stretched when matched against profitability: a 31.3% net margin and 67.0% ROE show that the company converts revenue into shareholder returns at a high rate. Still, a P/E above 50 requires the business to keep growing into the multiple; any slowdown in semiconductor capex could compress that figure quickly. The beta of 1.80 adds useful context for risk measurement: on average, LRCX has moved roughly 1.8 times the magnitude of the broader market, emphasizing that the reward profile is historically tied to the cyclicality of chip spending. As of the snapshot, the stock trades at $311.35, below the 50-day EMA of $318.34, with an RSI of 48.7, a neutral reading that neither screams overbought nor oversold.
Macro & geopolitical exposure
Because Lam Research is a semiconductor equipment company, its revenue is tightly linked to the global capital-expenditure cycle of chipmakers. The group is exposed to AI-driven data center buildouts, memory and logic node transitions, and foundry capacity expansions. When AI demand accelerates, customers such as leading-edge logic and DRAM producers tend to raise equipment purchases; when inventory corrections hit, orders can fall sharply. That boom-bust pattern is the dominant macro driver for the industry.
Beyond the demand cycle, the sector faces structural geopolitical and regulatory exposure. U.S., Chinese, European, and Japanese governments all treat semiconductor manufacturing as strategically important, which means export controls, tariffs, and subsidies can shift demand from one region to another almost overnight. Equipment makers are particularly vulnerable to restrictions on selling into Chinese fabs, because China represents a large share of global wafer-start capacity. Currency is another real variable: equipment contracts are frequently denominated in U.S. dollars, but local costs, financing rates, and customer budgets move with regional exchange rates. Supply-chain concentration in specialty components, rare gases, and high-purity materials adds further macro sensitivity, as does the level of interest rates, which affect how semiconductor manufacturers finance multi-billion-dollar fabs.
Recent developments
The most recent news flow has framed LRCX squarely inside the AI capex narrative. On August 7, 2026, Zacks published three relevant pieces. The first, “Tesla-SpaceX Terafab Bet: 4 Chip Equipment Stocks That Could Benefit,” tied Lam Research to a potential multi-fab buildout by Elon Musk-linked ventures and suggested equipment vendors could be indirect beneficiaries of such a large-scale project. The same day, Zacks ran “Semiconductor Sales Continue to Grow on AI Optimism: 4 Stocks to Grab,” placing LRCX on a list of chip-related stocks expected to ride improving industry sales. A third Zacks article asked, “Wall Street Analysts See Lam Research (LRCX) as a Buy: Should You Invest?,” signaling that sell-side sentiment had recently turned favorable, though readers should treat that as a headline rather than a personal recommendation.
The prior day, August 6, 2026, The Motley Fool published “Accenture vs. Lam Research: A Comparison of Revenue Growth and Stability,” which contrasted Lam’s cyclical, high-growth equipment model with Accenture’s steadier IT-consulting revenue stream. The comparison is useful: it reinforces that LRCX’s growth can be explosive during chip upcycles but is inherently more volatile than a service-based business. Collectively, the four stories paint a picture of a company benefiting from AI optimism and analyst upgrades, while still carrying the周期性 DNA of its sector.
Earnings behavior & post-earnings drift
LRCX has delivered an exceptionally consistent earnings record over the last eight reported quarters, beating consensus estimates on all 8 occasions. The average earnings surprise across those eight prints is 6.4%, and the average 5-day post-earnings move has been +4.2%, classified as an upward drift. That pattern suggests the market has generally underpriced Lam’s near-term results, and that positive surprises have had a tendency to keep working in the stock’s favor for several sessions after the release.
The most recent four quarters illustrate how headline beats can be accompanied by very different price paths. On July 29, 2026, Lam reported actual EPS of $1.82 against a consensus estimate of $1.69, an 8.5% surprise. The stock jumped 17.98% the next day and rallied 21.82% over the following five sessions. By contrast, the April 22, 2026 quarter saw actual EPS of $1.47 versus an estimate of $1.36, an 8.1% surprise, yet the stock fell 2.63% the next day and 6.33% over five sessions. The January 28, 2026 quarter produced a similar beat of 8.5% ($1.27 vs. $1.17) but delivered a 3.59% next-day gain followed by a 12.44% five-day decline. Even the October 22, 2025 quarter, with the smallest beat of the four at 3.3% ($1.26 vs. $1.22), managed a 4.45% next-day move and a 13.75% five-day advance.
The lesson from that volatility is straightforward: beating the published estimate does not guarantee a positive immediate reaction. Forward guidance, the market's real expectation embedded in the price, and sector sentiment can all override a headline beat. The next reported date to watch is October 21, 2026, after the market close, with a current consensus EPS estimate of $2.15. That estimate is up sharply from the $1.82 reported in July and the $1.47 from April, reflecting analysts’ expectation that AI-driven demand will continue to push Lam’s earnings higher.
Frequently Asked Questions
What does the 100% earnings beat rate over the last 8 quarters mean for LRCX?
It means Lam Research has reported actual EPS above the published consensus estimate in all eight of the most recent quarters, with an average surprise of 6.4%. Still, the stock’s post-earnings price reaction has varied widely, including some instances where the stock fell even though the company beat estimates.
Why does LRCX carry a beta of 1.80?
A beta of 1.80 means the stock has historically moved about 1.8 times the magnitude of the broader market. That reflects the semiconductor equipment industry’s sensitivity to capital spending cycles, AI demand trends, and geopolitical developments that affect chipmakers.
How did Lam Research’s most recent earnings report compare to expectations?
On July 29, 2026, the company reported actual EPS of $1.82 versus a consensus estimate of $1.69, a 7.7% positive surprise. The stock rose 17.98% the next trading day and climbed 21.82% over the following five sessions.
For a deeper dive into how sell-side analysts are modeling Lam Research’s AI-driven capex exposure, valuation, and risk factors, review the full institutional verdict available on the platform.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-29 | $1.82 | $1.69 | +7.7% | +17.98% | +21.82% |
| 2026-04-22 | $1.47 | $1.36 | +8.1% | -2.63% | -6.33% |
| 2026-01-28 | $1.27 | $1.17 | +8.5% | +3.59% | -12.44% |
| 2025-10-22 | $1.26 | $1.22 | +3.3% | +4.45% | +13.75% |
| 2025-07-30 | $1.33 | $1.21 | +9.9% | - | - |
| 2025-04-23 | $1.04 | $1 | +4% | - | - |
Previous LRCX editions
Get the institutional verdict on LRCX
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the LRCX verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.